International scientific guideline: Questions and answers on additional clarification for inclusion criteria in the 'Guideline on clinical investigation of medicinal products in the treatment of Parkinson's disease' rev. 2

About this guideline

Categories: Clinical efficacy and safety | Nervous system

Access this international scientific guideline

Further information: For information: 1 June 2014

For more information see International scientific guidelines adopted in Australia.

Where EU guidelines adopted in Australia include references to EU legislation (including EC Directives and Regulations), the requirements contained in the referenced EU legislation are not applicable to the evaluation of medicines by the TGA.